Toxic epidermal necrolysis in children - An update

Clinical Pediatrics

Volumn 39, Issue 12, 2000, Pages 687-694

  Ringheanu, Mihaela ^a   Laude, Teresita A ^b  

^a MAIMONIDES MEDICAL CENTER   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CORTICOSTEROID; IMMUNOGLOBULIN; PHENOBARBITAL;

ANTIBIOTIC THERAPY; ARTICLE; BLISTER; CHILD; CORTICOSTEROID THERAPY; DEHYDRATION; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ERYTHEMA; ERYTHEMA MULTIFORME; GASTROINTESTINAL DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY DISEASE; LUNG DISEASE; PATHOGENESIS; PROGNOSIS; SKIN EXFOLIATION; STEVENS JOHNSON SYNDROME; SUPERINFECTION; TOXIC EPIDERMAL NECROLYSIS; WOUND DRESSING;

EID: 0034538441     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992280003901201     Document Type: Article

References (38)

1. Luminal poisoning with conjunctival residue
2. Toxic epidermal necrolysis: An eruption resembling scalding of the skin
3. An unusual bullous eruption
4. Vascular reactions
5. Drug eruptions
6. Acute disseminated epidermal necrosis types 1, 2, and 3: Study of sixty cases
7. Genetic susceptibility to toxic epidermal necrolysis
8. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients
9. Toxic epidermal necrolysis. Incidence and drug etiology in France, 1981-1985
10. Involvement of macrophages in the pathology of toxic epidermal necrolysis
11. Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis
12. Experience with toxic epidermal necrolysis treated in a burn center
13. Impaired antigen presentation in toxic epidermal necrolysis
14. Lymphocyte transformation test in drug-induced toxic epidermal necrolysis
15. Erythema multiforme and toxic epidermal necrolysis: A comparative study
16. Toxic epidermal necrolysis. A study of sweat glands
17. Pulmonary complications in toxic epidermal necrolysis: A prospective clinical study
18. Bronchial obstruction due to respiratory sloughing in toxic epidermal necrolysis
19. Renal involvement in toxic epidermal necrolysis
20. Hematological disturbances and immune mechanisms in toxic epidermal necrolysis
21. Management of toxic epidermal necrolysis
22. Toxic epidermal necrolysis syndrome: Mortality rate reduced with early referral to regional burn center
23. Toxic epidermal necrolysis: An analysis of referral patterns and steroid usage
24. Burn center for patients with toxic epidermal necrolysis
25. Treatment of toxic epidermal necrolysis and a review of six cases
26. Management of Stevens-Johnson sydrome and toxic epidermal necrolysis in children
27. Biobrane wound dressing used in treatment of toxic epidermal necrolysis: A case report
28. Toxic epidermal necrolysis: An approach to management using cryopreserved allograft skin
29. Toxic epidermal necrolysis
30. Care of the burn wound
31. Drug-induced toxic epidermal necrolysis in children
32. Plasma exchange treatment in drug-induced toxic epidermal necrolysis
33. Plasmapheresis in toxic epidermal necrolysis
34. Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis
35. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
36. Recombinant granulocyte colony-stimulating factor in the management of toxic epidermal necrolysis
37. Hyperbaric oxygen treatment of toxic epidermal necrolysis
38. Nutrition requirements in patients with toxic epidermal necrolysis